Liquidia

Develops and commercializes inhaled therapies for rare cardiopulmonary diseases.

Founded 2004 · 216 employees · United States · Public

Listed:

NASDAQ: LQDA

Subsidiaries:

Liquidia Technologies, Liquidia PAH